An ongoing dialogue on HIV/AIDS, infectious diseases,
June 13th, 2009
Occupational Exposures and HIV Testing
A couple of years ago, an ID-colleague of mine told me about a tough case: While working in the ICU, an anesthesiologist sustained a pretty severe needle stick. Approached for HIV testing, the source of the exposure felt threatened by the providers in the ICU, and refused to sign the consent.
The patient then deteriorated and required intubation. The intensivist, understandably in something of a panic, contacted my colleague for advice.
We’re about to post this case — actual details of which are slightly changed to protect anonymity — in AIDS Clinical Care. We’ve asked some experts (MD, lawyer, ethicist) on the matter a few key questions, including:
- How would you manage the intensivist who sustained the injury?
- Would you give post-exposure prophylaxis? If so, what specifically would you give, and for how long?
- How would you determine if the source patient has HIV? Would you perform surrogate testing (for example, obtain a CD4-cell count) to assess this? Would you consider testing him without written informed consent?
- If he is tested, would you give him the results after he recovers if the test is negative? If the test is positive?
This case is different from the this one, but many of the issues are related. (Different from this one too, obviously.)
And it’s a reminder that amidst all the controversy over “opt-out” testing and HIV screening, there’s another big issue out there regarding HIV testing that’s hardly been settled.
Categories: Antiretroviral Rounds, Health Care, HIV, Infectious Diseases, Patient Care, Policy
Tags: AIDS, aids clinical care, cd4 cell count, HIV, HIV testing, informed consent, intensivist, occupational exposures, post-exposure prophylaxis
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
4 Responses to “Occupational Exposures and HIV Testing”

Paul E. Sax, MD
Associate Editor
NEJM Clinician
Biography | Disclosures & Summaries
Learn more about HIV and ID Observations.
Search this Blog
Follow HIV and ID Observations Posts via Email
Archives
Most Popular Posts
Sorry. No data so far.
-
From the Blog — Most Recent Articles
- Farewell to This Blog — and Hello to NEJM Voices March 2, 2026
- Some Ruminations on CROI — Still the Best HIV Meeting February 26, 2026
- Two Things Can Be True: The FDA Process Was Inconsistent, and the mRNA Vaccine Data Were Disappointing February 17, 2026
- Sometimes You Just Need to Get Input from a Real Human Being February 12, 2026
- Mystifying Abbreviations — Infectious Diseases Edition February 4, 2026
FROM NEJM — Recent Infectious Disease Articles- Andes Hantavirus Outbreak on a Cruise Ship, 2026 June 25, 2026On May 2, hantavirus infection was diagnosed in a patient who had been on a cruise ship. Subsequent evaluation revealed multiple cases of Andes hantavirus infection on the ship. To date, three associated deaths have occurred.
- Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection June 25, 2026In two phase 3 trials, 19% of patients with chronic hepatitis B infection had a functional cure with the antisense oligonucleotide bepirovirsen, 24 weeks after stopping all HBV treatment; functional cure was not seen with placebo.
- Clusters of Concern — Spatial Link between Childhood Undervaccination and Measles Outbreaks in South Carolina June 25, 2026Spatial analysis in South Carolina revealed that measles infections were clustered in areas where public school vaccination rates were lower.
- Improving Global Air-Quality Indices — The WHO’s New Roadmap June 25, 2026Many countries rely on air-quality indices to inform the public and help protect people during short-term increases in air pollution. Their use has important societal and economic implications.
- A Major Step toward a Cure for Hepatitis B Infection June 25, 2026The current treatment of chronic hepatitis B infection includes nucleoside or nucleotide analogue (NA) therapy and pegylated interferon. Both of these treatments are effective in suppressing hepatitis B virus (HBV) replication and in reducing the risk of cirrhosis and hepatocellular carcinoma.1 However, these treatments do not eradicate HBV,...
- Andes Hantavirus Outbreak on a Cruise Ship, 2026 June 25, 2026
-
Tag Cloud
- Abacavir AIDS antibiotics antiretroviral therapy ART atazanavir baseball Brush with Greatness CDC C diff COVID-19 CROI darunavir dolutegravir elvitegravir etravirine FDA HCV hepatitis C HIV HIV cure HIV testing ID fellowship ID Learning Unit Infectious Diseases influenza Link-o-Rama lyme disease medical education MRSA PEP PrEP prevention primary care raltegravir Really Rapid Review resistance Retrovirus Conference rilpivirine sofosbuvir TDF/FTC tenofovir Thanksgiving vaccines zoster

When I sustained my stick injury in the ICU the laws in my state clearly gave the patients treating physician the right to either test an existing blood sample or obtain a new one to determine if any transmissible pathogens could be identified (without patient consent). Most ICU patients have a lot of blood work in the lab or on the way there. My patient had undiagnosed, advanced HIV and was subsequently offered treatment which was accepted by the family. I received triple prophylaxis and never seroconverted. This is an occupation hazard issue and also meets the common sense/decency/fairness standard unpon which many laws are derived. At this point there are now two patients to consider and not just one although respect for the autonomy of the index case is clearly important. There is a double effect and one might argue to just treat the worker as though positive although hep C and HIV prophylaxis for six months would not be a picnic. Mediation via hospital clergy or ICU nurses who often have close relationships with the family or others to find a solution for all concerned might help if the patient refused or was suspicious of the ICU attendings. If my patients family had refused testing but given me some reasonable explaination for the refusal I would have understood and just taken the drugs anyway.
>>>When I sustained my stick injury in the ICU the laws in my state clearly gave the patients treating physician the right to either test an existing blood sample or obtain a new one to determine if any transmissible pathogens could be identified (without patient consent).
I have heard that this is the case in many states — very sensible. Not so in MA, unfortunately!
Paul
a newborn’s “need to know” not only trumps the source case’s right to refuse, but even takes precedence over a parent’s right to consent or refuse intervention on one’s child.
Doesn’t a health care worker who sustained a needle stick have an equally compelling need to know that ought to be recognized by the state?
Liz Jenny,
I tend to agree. Protection of the worker, an OSHA issue.
However, our opinion on this matter seems — at least in public statements — to be in the minority.